PAM
TENX icon

Panagora Asset Management’s Tenax Therapeutics TENX Stock Holding History

Panagora Asset Management’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.27M Buy
+156,062
New +$1.99M 0.01% 611

Other funds holding TENX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.36B AUM 25.57% 1-Year Est. Return

Panagora Asset Management's TENX Position: Q2 2026 in Review

Panagora Asset Management opened a new position in Tenax Therapeutics (TENX) in Q2 2026: 156,062 shares worth $2.27M. The stake represents 0.01% of the portfolio and ranks #611 among its holdings.

23 funds tracked by Wall St. Rank hold TENX as of Q2 2026.

  • Panagora Asset Management held 156,062 shares of Tenax Therapeutics worth $2.27M as of Q2 2026.
  • Tenax Therapeutics was a new Panagora Asset Management position in Q2 2026.
  • Tenax Therapeutics made up 0.01% of Panagora Asset Management's portfolio in Q2 2026, its #611 holding.
  • 23 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q2 2026.

Based on Panagora Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.